Tech Company Financing Transactions

Aligos Therapeutics Funding Round

Wellington Management Company, Boxer Capital and Cormorant Asset Management participated in a $125 million Series B venture round for Aligos Therapeutics. The financing round was announced on 1/13/2020.

Transaction Overview

Announced On
1/13/2020
Transaction Type
Venture Equity
Amount
$125,000,000
Round
Series B
Investors

Wellington Management Company (Lead Investor)

Boxer Capital

Cormorant Asset Management

Janus Henderson Investors

Logos Capital

Pivotal bioVenture Partners

Proceeds Purpose
This round of funding provides Aligos with the capital needed to move our portfolio of products aimed at treatment of chronic hepatitis B into clinical development.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Corporate Drive 2nd Floor
South San Francisco, CA 94080
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Aligos Therapeutics (Nasdaq: ALGS) discovers targeted antiviral therapies for chronic hepatitis B (CHB), COVID-19, and optimized therapeutics for Nonalcoholic Steatohepatitis (NASH).
Profile
Aligos Therapeutics LinkedIn Company Profile
Social Media
Aligos Therapeutics Company Twitter Account
Company News
Aligos Therapeutics News
Facebook
Aligos Therapeutics on Facebook
YouTube
Aligos Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Lawrence Blatt
  Lawrence Blatt LinkedIn Profile  Lawrence Blatt Twitter Account  Lawrence Blatt News  Lawrence Blatt on Facebook
Chief Financial Officer
Lesley Calhoun
  Lesley Calhoun LinkedIn Profile  Lesley Calhoun Twitter Account  Lesley Calhoun News  Lesley Calhoun on Facebook
Chief Medical Officer
Matthew McClure
  Matthew McClure LinkedIn Profile  Matthew McClure Twitter Account  Matthew McClure News  Matthew McClure on Facebook
Chief Scientific Officer
Julian Symons
  Julian Symons LinkedIn Profile  Julian Symons Twitter Account  Julian Symons News  Julian Symons on Facebook
President
Leonid Beigelman
  Leonid Beigelman LinkedIn Profile  Leonid Beigelman Twitter Account  Leonid Beigelman News  Leonid Beigelman on Facebook
VP - General Counsel
Lucinda Quan
  Lucinda Quan LinkedIn Profile  Lucinda Quan Twitter Account  Lucinda Quan News  Lucinda Quan on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/13/2020: IsoPlexis venture capital transaction
Next: 1/13/2020: Tyton BioSciences venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary